Rapid Whole Genome Sequencing: It Is Feasible! When Can We Implement It?
- PMID: 38898915
- PMCID: PMC11185199
- DOI: 10.1177/15357597241237349
Rapid Whole Genome Sequencing: It Is Feasible! When Can We Implement It?
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Comment on
-
Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study.Lancet Neurol. 2023 Sep;22(9):812-825. doi: 10.1016/S1474-4422(23)00246-6. Lancet Neurol. 2023. PMID: 37596007 Free PMC article.
References
-
- D'Gama AM, Mulhern S, Sheidley BR, et al. Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study. Lancet Neurol. 2023;22(9):812–825. doi:10.1016/S1474-4422(23)00246-6 - PubMed
-
- Sheidley BR, Malinowski J, Bergner AL, et al. Genetic testing for the epilepsies: a systematic review. Epilepsia. 2022;63(2):375–387. - PubMed
-
- Smith L, Malinowski J, Ceulemans S, et al. Genetic testing and counseling for the unexplained epilepsies: an evidence-based practice guideline of the National Society of Genetic Counselors. J Genet Couns. 2023;32(2):266–280. - PubMed
-
- Diaby V, Babcock A, Huang Y, et al. Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United States. Pharmacogenomics J. 2022;22(4):223–229. - PubMed
Publication types
LinkOut - more resources
Full Text Sources